missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant Human Neurexin 2 alpha Isoform 2 Fc Chimera
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
Brand: R&D Systems™ 6636-NX-025
This item is not returnable.
View return policy
Description
The Recombinant Human Neurexin 2 alpha Isoform 2 Fc Chimera is derived from CHO. The Recombinant Human Neurexin 2 alpha Isoform 2 Fc Chimera has been validated for the following applications: Bioactivity.Specifications
| Lyophilized from a 0.2μm filtered solution in PBS. | |
| 193 kDa (monomer) | |
| 25 μg | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. | |
| Unconjugated | |
| 95%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
| 9379 | |
| Neurexin 2 alpha/NRXN2a Isoform 2 Fc Chimera | |
| Chinese Hamster Ovary cell line,CHO-derived human Neurexin 2 alpha/NRXN2a protein, (N-terminus) Human Neurexin 2 alpha (Met1-Thr1566) Accession &Num; NP_620060 IEGRMD Human IgG1 (Pro100-Lys330) (C-terminus) | |
| Disulfide-linked homodimer | |
| Recombinant |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction